LOS ANGELES - The Moderna COVID-19 vaccine represented strong immune memories of the novel coronavirus six months after receiving a second dose, according to a recent report from the National Institutes of Health.
When NIH researchers discuss immune memories, they are referring to immune cells called T cells that retain viral data and linger in the body helping fight off against unwanted illnesses like COVID-19.
The report was published on Oct. 5 and sheds light on how lasting immunity against COVID-19 develops after vaccination. A team of researchers analyzed data from 35 participants enrolled in phase 1 clinical trial of the Moderna vaccine and followed up six months after their final dose. RELATED: Moderna: Vaccine 93% effective up to 6.